Related Experiment Video
Updated: Dec 21, 2025

10:39
Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
Published on: June 25, 2015
13.0K
Recent advances in influenza vaccines
Graham Pawelec1,2, Janet McElhaney2
1Department of Immunology, University of Tübingen, Tübingen, Germany.
F1000Research
|May 14, 2020
Summary
Seasonal influenza causes hundreds of thousands of deaths annually, primarily in the elderly. Improving influenza vaccines, including universal options, is crucial for public health, especially given current challenges.
Area of Science:
- Immunology
- Public Health
- Virology
Background:
- Seasonal influenza is a significant global health threat, causing substantial mortality, particularly among older adults.
- Current influenza vaccines face challenges including viral variability, production issues, administration methods, and reduced efficacy in the elderly.
- Suboptimal clinical protection and low vaccine uptake necessitate advancements in influenza immunization strategies.
Purpose of the Study:
- To assess progress in developing more effective influenza vaccines over the past three years.
- To explore strategies for creating universal influenza vaccines that are independent of seasonal strains.
- To evaluate methods for enhancing both cellular and humoral immune responses, especially in elderly populations.
Main Methods:
- This commentary reviews recent scientific literature and developments in influenza vaccine research.
- It analyzes advancements in vaccine design, including approaches to broaden immune responses.
- The impact of the SARS-CoV-2 pandemic on influenza research efforts is also considered.
Main Results:
- Progress has been made towards developing influenza vaccines with improved effectiveness and broader applicability.
- The development of universal influenza vaccines and strategies to boost immunity in the elderly are key areas of focus.
- Lessons learned from SARS-CoV-2 vaccine development may offer synergistic benefits for influenza vaccine innovation.
Conclusions:
- Despite challenges, ongoing research is vital for improving influenza vaccines due to the virus's persistence.
- Universal vaccines and enhanced immunogenicity, particularly in vulnerable groups, represent critical future directions.
- Continued investment in influenza vaccine research is essential for mitigating the global burden of seasonal flu.
Related Concept Videos
Vaccinations
50.9K
Overview
50.9K
Microorganisms in Medicine and Therapeutics
832
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
832

